1. Home
  2. AERT vs ANEB Comparison

AERT vs ANEB Comparison

Compare AERT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$0.56

Market Cap

27.9M

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.19

Market Cap

96.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
ANEB
Founded
2012
2020
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
96.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AERT
ANEB
Price
$0.56
$1.19
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
163.9K
79.7K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.90
52 Week High
$2.67
$3.42

Technical Indicators

Market Signals
Indicator
AERT
ANEB
Relative Strength Index (RSI) 44.48 19.23
Support Level $0.54 $1.91
Resistance Level $0.59 $2.40
Average True Range (ATR) 0.06 0.19
MACD 0.00 -0.08
Stochastic Oscillator 26.55 3.97

Price Performance

Historical Comparison
AERT
ANEB

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: